A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorStéphane Morandi
About this trial
The goal of this randomized control trial is to assess the effectiveness of a Brief Case Management (BCM) intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital.
The main questions it aims to answer are :
* Does the Brief Case Management intervention reduce the incidence of involuntary readmission18 months after the initial involuntary hospitalisation? * What impact does the Brief Case Management intervention have on patients' involuntary readmission 6 months after the initial involuntary hospitalisation, as well as on their personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion?
Participants will be randomly assigned to either the control or the intervention group, accordingly they will be asked to take part in:
Control Group:
* Three evaluation sessions (baseline, 6 and 18 months follow-up);
Intervention Group :
* Three evaluation sessions (baseline, 6 and 18 months follow-up); * The 5 sessions of the brief case management intervention (6th session optional).
Eligibility criteria
Qualifiers
To have been involuntarily admitted by a medical doctor;
To be aged between 18 and 64 years;
To domiciled in the Greater Lausanne area;
Disqualifiers
Patients with an organic mental disorder (F0, ICD-10);
Patients with intellectual disability (F7, ICD-10);
Patients unable to provide written consent due to a lack of discernment;
Patients unable to speak French well enough to participate in the study without the help of an interpreter.
Trial design
Treatments tested in this trial
- Brief Case Management intervention
- TAU
Treatment groups
262 Participants
are divided into 2 treatment groupsSponsors and collaborators
Stéphane Morandi
Lead sponsor
University of Lausanne Hospitals
Sponsor institution
University of Lausanne
Collaborator
Source ClinicalTrials.gov